SEC Form 4 · accession 0001437749-19-003666
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven D Goldby
Director
Period of report
Feb 28, 2019
Accepted (ET)
Feb 28, 2019 · 8:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 28, 2019 | M | 5,000 | $6.66 | A | 71,490 | D | |
| Common Stock | Feb 28, 2019 | F | 2,593 | $12.84 | D | 68,897 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nonstatutory Stock Option (Right to Buy) | $6.66 | Feb 28, 2019 | M | 5,000 | D | May 16, 2012 | May 16, 2019 | Common Stock | 5,000 | 5,000 | D |